Literature DB >> 4332253

Protein synthesis directed by encephalomyocarditis virus RNA: properties of a transfer RNA-dependent system.

H Aviv, I Boime, P Leder.   

Abstract

Small amounts of encephalomyocarditis virus RNA direct a 50-fold increase in amino acid incorporation, in appropriately supplemented ascites tumor cell extracts, under conditions that give rise to authentic viral polypeptides. Incorporation in these crude extracts has a novel characteristic, namely, that it is almost entirely dependent upon the addition of exogenous tRNA. Further, this incorporation is restricted in that tRNA derived from ascites tumor cells or from rat liver permits translation of viral RNA, whereas tRNA from yeast or Escherichia coli does not. These translational barriers are due, at least in part, to an incompatibility between the tRNA of yeast and E. coli and the aminoacyl-tRNA synthetases of the ascites tumor cell. A more extensive basis for this incompatibility is suggested, however, by the failure of the E. coli aminoacyl-tRNA synthetases to restore viral RNA-directed protein synthesis in the presence of tRNA from E. coli, although the coli synthetases fully restore the poly(U)-directed synthesis of polyphenyl-alanine. The possible role that unique or favored codon classes might play in this restriction is considered, together with the implications of the observed requirement for tRNA.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4332253      PMCID: PMC389405          DOI: 10.1073/pnas.68.9.2303

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  SPECIES SPECIFICITY OF AMINO ACID ACCEPTOR RIBONUCLEIC ACID AND AMINOACYL SOLUBLE RIBONUCLEIC ACID SYNTHETASES.

Authors:  B P DOCTOR; J A MUDD
Journal:  J Biol Chem       Date:  1963-11       Impact factor: 5.157

2.  Virus protein synthesis in animal cell-free systems: nature of the products synthesized in resonse to ribonucleic acid of encephalomyocarditis virus.

Authors:  I M Kerr; E M Martin
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

3.  Isolation of amino acid acceptor RNA from purified avian myeloblastosis virus.

Authors:  E Erikson; R L Erikson
Journal:  J Mol Biol       Date:  1970-09-14       Impact factor: 5.469

4.  Purification of Encephalomyocarditis virus.

Authors:  A T Burness
Journal:  J Gen Virol       Date:  1969-09       Impact factor: 3.891

5.  RNA with amino acid-acceptor activity isolated from an oncogenic virus.

Authors:  M Trávnícek
Journal:  Biochim Biophys Acta       Date:  1968-10-29

6.  RNA codons and protein synthesis. 15. Dissimilar responses of mammalian and bacterial transfer RNA fractions to messenger RNA codons.

Authors:  C T Caskey; A Beaudet; M Nirenberg
Journal:  J Mol Biol       Date:  1968-10-14       Impact factor: 5.469

7.  The synthesis of mouse hemoglobin beta-chains in a rabbit reticulocyte cell-free system programmed with mouse reticulocyte 9S RNA.

Authors:  R E Lockard; J B Lingrel
Journal:  Biochem Biophys Res Commun       Date:  1969-10-08       Impact factor: 3.575

8.  Transfer RNA species in normal and leukemic human lymphoblasts.

Authors:  R C Gallo; S Pestka
Journal:  J Mol Biol       Date:  1970-09-14       Impact factor: 5.469

9.  Roles of methionine transfer RNA's in protein synthesis in rabbit reticulocytes.

Authors:  N K Gupta; N K Chatterjee; K K Bose; S Bhaduri; A Chung
Journal:  J Mol Biol       Date:  1970-11-28       Impact factor: 5.469

10.  Protein synthesis in cell-free systems: an effect of interferon.

Authors:  I M Kerr
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

View more
  33 in total

1.  Regulation of synthesis of hepatic fatty acid synthetase: polysomal translation in a cell-free system.

Authors:  A W Strauss; A W Alberts; S Hennessy; P R Vagelos
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

2.  Interferon activity produced by translation of human interferon messenger RNA in cell-free ribosomal systems and in Xenopus oöcytes.

Authors:  F H Reynolds; E Premkumar; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

3.  Isolation and characterization of collagen messenger RNA*.

Authors:  L Wang; C L Simões; S Sonohara; M Brentani; H F Andrade; S M da Silva; J M Salles; N Marques; R Brentani
Journal:  Nucleic Acids Res       Date:  1975-05       Impact factor: 16.971

4.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

5.  Purification and properties of biologically active messenger RNA for a myeloma light chain.

Authors:  D Swan; H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

6.  Specific changes in the messenger ribonucleic acid content of the rat ventral prostate gland after androgenic stimulation. Evidence from the synthesis of aldolase messenger ribonucleic acid.

Authors:  W I Mainwaring; F R Mangan; R A Irving; D A Jones
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

7.  Biologically and chemically pure mRNA coding for a mouse immunoglobulin L-chain prepared with the aid of antibodies and immobilized oligothymidine.

Authors:  I Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

8.  Formation of Sindbis virus capsid protein in mammalian cell-free extracts programmed with viral messenger RNA.

Authors:  R Cancedda; M J Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

9.  Isolation and in vitro translation of delta-crystallin mRNA from embryonic chick lens fibers.

Authors:  P Zelenka; J Piatigorsky
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage.

Authors:  Alfredo Castelló; David Franco; Pablo Moral-López; Juan J Berlanga; Enrique Alvarez; Eckard Wimmer; Luis Carrasco
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.